# Treatment of Chronic Lymphocytic Leukemia

> **NCT02757586** · — · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Leukemia, Lymphocytic, Chronic, B-Cell

## Interventions

- **GENETIC:** shRNA

## Key facts

- **NCT ID:** NCT02757586
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2016-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757586, "Treatment of Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02757586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
